PLYMOUTH, Minn., June 6, 2023 /PRNewswire/ -- GIE Medical, a clinical stage company developing solutions for patients suffering from benign stricture(s) of the esophagus or bowel, was granted ...
GIE Medical Announces First Patient Enrolled in PATENT-E Benign Esophageal Stricture Treatment Study
The large, multicenter randomized controlled clinical trial is evaluating the safety and efficacy of the ProTractX3™ TTS drug coated balloon for the treatment of benign esophageal strictures ...
GIE Medical has launched two large, multicenter randomized controlled clinical trials in the United States to investigate ProTractX3™ TTS DCB. GIE Medical’s ProTractX3™ 3-Stage TTS DCB is a balloon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback